Natus Medical Inc(NTUS) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders; head-cooling products for the treatment of brain injury in newborns; and incubators to control the newborn's environment. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, and governmental agencies. The company was founded in 1987 and is headquartered in Pleasanton, California.

Current Price

$26.62

RSI

55.883

Beta:

0.537231

February 26, 2021
55.8M
16.3M

-9.662 %
-12.153 %
-12.890 %
-381.305 %

$415,684,000
$495,175,000
$530,891,000
$500,970,000
$381,892,000
$375,865,000
-19.123 %
-7.213 %
5.973 %
31.181 %
1.604 %

$-22,065,000
$-21,257,000
$-32,260,000
$5,150,000
$54,903,000
$52,409,000
-3.662 %
51.762 %
-115.964 %
-966.078 %
4.759 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.